Covidien's (COV) earnings continue an emerging theme this quarter - stagnant revenue growth in...

|By:, SA News Editor

Covidien's (COV) earnings continue an emerging theme this quarter - stagnant revenue growth in pharmaceuticals and better performance in devices.